Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ce |
RCV001092365 | SCV001248833 | pathogenic | not provided | 2016-09-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001092365 | SCV001406272 | uncertain significance | not provided | 2021-08-31 | criteria provided, single submitter | clinical testing | This sequence change replaces methionine with threonine at codon 12 of the EYS protein (p.Met12Thr). The methionine residue is weakly conserved and there is a moderate physicochemical difference between methionine and threonine. This variant is present in population databases (rs755947942, ExAC 0.03%). This missense change has been observed in individual(s) with retinal disease (PMID: 26161267). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Mendelics | RCV002249681 | SCV002517036 | uncertain significance | not specified | 2022-05-04 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV003469288 | SCV004192898 | likely pathogenic | Retinitis pigmentosa 25 | 2023-12-26 | criteria provided, single submitter | clinical testing | |
Dept Of Ophthalmology, |
RCV003890233 | SCV004704687 | likely pathogenic | Retinal dystrophy | 2023-10-01 | criteria provided, single submitter | research |